A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers
一项关于CD40激动剂抗体Sotigalimab联合同步放化疗作为食管癌和胃食管交界处癌新辅助治疗的II期研究
期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-24-0513
Ko, Andrew H; Chao, Joseph; Noel, Marcus S; Shankaran, Veena; Sohal, Davendra; Crow, Mary; Oberstein, Paul E; Scott, Aaron J; McRee, Autumn J; Rocha Lima, Caio Max Sao Pedro; Fong, Lawrence; Keenan, Bridget P; Soto, Maira; Filbert, Erin L; Hsu, Frank J; Yang, Xiaodong